|
|
|
05 Dec 2007 |
BioAlliance Pharma acquires the European commercialization rights to pafuramidine for the treatment of Pneumocystis carinii pneumonia
|
|
04 Dec 2007 |
HRA Pharma enters licensing agreement with PregLem to develop and commercialise ulipristal for gynecological disorders
|
|
03 Dec 2007 |
Addex and Merck & Co. Collaborate to Develop Drugs for Parkinson's Disease
|
|
03 Dec 2007 |
Santarus Licenses Rights to GlaxoSmithKline for ZEGERID Immediate-Release Omeprazole Products in over 100 Countries
|
|
03 Dec 2007 |
Clal Biotechnology Industries and Teva Pharmaceuticals Solidify their Collaboration for Final Stage Development of Type 1 Diabetes Drug
|
|
28 Nov 2007 |
MediGene and Celltrion Announce Co-development of Anti-L1 Monoclonal Antibody Therapeutic for Treating Cancer
|
|
27 Nov 2007 |
Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases
|
|
27 Nov 2007 |
Urigen Signs Licensing Agreement with Mattern for Phase II Treatment of Hypogonadism
|
|
23 Nov 2007 |
Bristol-Myers Squibb and Pierre Fabre Provide Update On Vinflunine Development Status
|
|
20 Nov 2007 |
Anika Therapeutics and Galderma Agree to Terminate License, Development and Supply Agreements
|
|
19 Nov 2007 |
Genelabs Technologies regains exclusive rights to Prestara (TM) in Japan from Mitsubishi Tanabe Pharma Corporation
|
|
19 Nov 2007 |
Meyer Pharmaceuticals acquires NF-kappa b decoy technology for treatment of inflammatory disease
|
|
19 Nov 2007 |
Inhibitex Obtains License To HCV Polymerase Inhibitors
|
|
15 Nov 2007 |
Sanofi Pasteur and Acambis join forces to bring West Nile vaccine to market
|
|
14 Nov 2007 |
Merck Serono Exercises Option to Rigel's R763/AS703569 and Aurora Kinase Inhibitors in the Japanese Territory
|
|
14 Nov 2007 |
Cyberkinetics and NeuroMetrix Forge Strategic Alliance and Agree to Pursue Joint Venture Aimed at Developing Andara(TM) OFS(TM) Therapy for Peripheral Nerve Injury
|
|
12 Nov 2007 |
Infinity Announces Hedgehog Pathway Inhibitor Agreement With AstraZeneca
|
|
08 Nov 2007 |
Shire expands its Human Genetic Therapies pipeline through in-licensing agreement with Amicus Therapeutics
|
|
07 Nov 2007 |
GTx, Inc. and Merck & Co., Inc. Enter Global Strategic Collaboration for the Development of SARMs, a Novel Investigational Class of Drugs to Treat Muscle Loss and other Musculoskeletal Conditions
|
|
07 Nov 2007 |
Biovail Enters into Development Agreement
|
|
05 Nov 2007 |
Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug
|
|
02 Nov 2007 |
Dynavax and Merck & Co., Inc. Announce Partnership to Develop HEPLISAV(TM), an Investigational Hepatitis B Vaccine Currently in Phase 3
|
|
02 Nov 2007 |
Neurocrine Biosciences and Dainippon Sumitomo Pharma (DSP) Announce Agreement to Develop and Commercialize Indiplon in Japan
|
|
01 Nov 2007 |
Seattle Genetics and MedImmune Expand Antibody-Drug Conjugate Collaboration
|
|
01 Nov 2007 |
Ipsen and Debiopharm extend their agreement for the exclusive commercialization of Decapeptyl(R) in Europe and certain other territories
|
|
01 Nov 2007 |
Debiopharm and Nanocarrier sign License and Supply Agreement for DACH-Platin Polymeric Micelle in Oncology
|
|
31 Oct 2007 |
Sapphire Therapeutics Licenses Ghrelin Antagonist Program from Novo Nordisk for Development of Obesity Treatments
|
|
31 Oct 2007 |
Organon signs an exclusive, worldwide licence agreement on advanced antithrombotic compounds with Endotis Pharma
|
|
30 Oct 2007 |
Lilly and Glenmark Pharmaceuticals Announce License Agreement
|
|
30 Oct 2007 |
Taisho and Pfizer Sign a Letter of Intent for Taisho's Schizophrenia Drug Candidate
|
|
24 Oct 2007 |
GlaxoSmithKline And Tolerx Form Worldwide Collaboration For Development And Commercialization Of Novel Medication
|
|
20 Oct 2007 |
BioWa Announces Licensing of POTELLIGENT(R) Technology by GlaxoSmithKline (GSK)
|
|
18 Oct 2007 |
Lilly and MacroGenics Announce Licensing and Collaboration Agreement
|
|
16 Oct 2007 |
Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
|
|
16 Oct 2007 |
Pharmacopeia Acquires Selective Androgen Receptor Modulator ("SARM") Program from Bristol-Myers Squibb
|
|
16 Oct 2007 |
XenoPort and Xanodyne Announce Exclusive U.S. Licensing Agreement for XP21510
|
|
11 Oct 2007 |
GlaxoSmithKline and Synta Pharmaceuticals Announce Development and Commercialization Collaboration for STA-4783 in Oncology
|
|
09 Oct 2007 |
GlaxoSmithKline and Anacor Pharmaceuticals form alliance to develop systemic antivirals and antibiotics based on boron chemistry
|
|
05 Oct 2007 |
ThromboGenics and Rhein Minapharm Announce Agreement
|
|
05 Oct 2007 |
TopoTarget and Lundbeck sign agreement forsiramesine, a new and promising mechanism in cancer therapy
|
|
04 Oct 2007 |
MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
|
|
02 Oct 2007 |
BioLineRx In-Licenses Novel Peptide BL-4050 for the Treatment of Cancer
|
|
02 Oct 2007 |
Kissei and Eisai sign a license agreement to develop and commercialize Glufast(R), a rapid-acting insulin secretagogue in China
|
|
28 Sep 2007 |
Prexige(R) receives ''not approvable'' letter in the US despite being one of the most studied COX-2 inhibitors
|
|
27 Sep 2007 |
OctoPlus in-licenses diabetes product candidate
|
|
27 Sep 2007 |
ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments
|
|
27 Sep 2007 |
JT and Torii Sign Licensing Agreement with Keryx for Development and Commercialization of Hyperphosphatemia Drug in Japan
|
|
27 Sep 2007 |
NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors
|
|
27 Sep 2007 |
Nycomed and NPS Pharmaceuticals Announce Licensing Agreement for GATTEX(TM)
|
|
27 Sep 2007 |
Protherics licenses its CoVaccine HT adjuvant to Nobilon for influenza vaccine indications
|
| |
|
Results 201 - 250 of 815 |
